# SELEXYS PHARMACEUTICALS CORP: Form D filings

SELEXYS PHARMACEUTICALS CORP, a biotechnology company in Oklahoma City, OK, filed 6 Form D notices with the SEC between 2009 and 2015. The latest, on February 23, 2015, reports $43.2 million sold of a $43.2 million offering to 57 investors.

Find out what SELEXYS PHARMACEUTICALS CORP does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20SELEXYS%20PHARMACEUTICALS%20CORP%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=SELEXYS%20PHARMACEUTICALS%20CORP&page=%2Fdata%2Fform-d%2Fcompany%2Fselexys-pharmaceuticals-corp-1442824)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20SELEXYS%20PHARMACEUTICALS%20CORP%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=SELEXYS%20PHARMACEUTICALS%20CORP&page=%2Fdata%2Fform-d%2Fcompany%2Fselexys-pharmaceuticals-corp-1442824)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Oklahoma](https://specstream.ai/data/form-d/state/oklahoma): 227 rows, by operating companies, filed since November 1, 2024, $11.35, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/oklahoma
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 840 RESEARCH PARKWAY, SUITE 516, Oklahoma City, OK, 73104
- Phone: (405) 319-8198
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: No Revenues
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1442824

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Feb 23, 2015 | Amendment | $43,196,831 | $43,196,831 | $0 | 57 | Sep 17, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1442824/000114036115008408/0001140361-15-008408-index.htm) |
| Oct 2, 2012 | New notice | $45,659,537 | $34,459,532 | $11,200,005 | 57 | Sep 17, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1442824/000114036112042306/0001140361-12-042306-index.htm) |
| Nov 4, 2011 | Amendment | $5,000,000 | $5,000,000 | $0 | 34 | Nov 21, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1442824/000114036111051706/0001140361-11-051706-index.htm) |
| Apr 20, 2011 | Amendment | $5,000,000 | $2,800,000 | $2,200,000 | 25 | Nov 21, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1442824/000114036111022664/0001140361-11-022664-index.htm) |
| Dec 1, 2010 | New notice | $5,000,000 | $200,000 | $4,800,000 | 2 | Nov 21, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1442824/000114036110047606/0001140361-10-047606-index.htm) |
| Jul 2, 2009 | Amendment | $3,435,000 | $3,435,000 | $0 | 31 | Aug 11, 2008 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1442824/000144282409000002/0001442824-09-000002-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| David Falconer | Executive Officer |  |
| Philip Jones, M.D. | Director |  |
| David Keiser | Director |  |
| Richard Alvarez | Executive Officer |  |
| Todd Foley | Director |  |
| Russell Rother | Executive Officer |  |
| Rodger McEver, M.D. | Director |  |
| Scott Rollins, Ph.D. | Executive Officer, Director |  |

## Other biotechnology companies in Oklahoma that filed recently

- [Endless Corp](https://specstream.ai/data/form-d/company/endless-corp-2043905) $100,000 · Aug 19, 2026

[Every Form D from the week of Feb 23, 2015](https://specstream.ai/data/form-d/week/2015-02-23) · [All recent filings in Oklahoma](https://specstream.ai/data/form-d/state/oklahoma) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what SELEXYS PHARMACEUTICALS CORP reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).